D.E. Shaw & Co’s Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 HLGN.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-242,523
Closed -$8.95K 4765
2023
Q3
$8.95K Hold
242,523
﹤0.01% 4078
2023
Q2
$11.1K Hold
242,523
﹤0.01% 4039
2023
Q1
$9.58K Hold
242,523
﹤0.01% 4240
2022
Q4
$18.2K Hold
242,523
﹤0.01% 4539
2022
Q3
$53K Hold
242,523
﹤0.01% 4682
2022
Q2
$64K Sell
242,523
-4,456
-2% -$2.64K ﹤0.01% 4805
2022
Q1
$304K Hold
246,979
﹤0.01% 4644
2021
Q4
$420K Buy
+246,979
New +$420K ﹤0.01% 4504

Other funds holding HLGN.WS

D.E. Shaw & Co's HLGN.WS Position: Q4 2023 in Review

D.E. Shaw & Co sold out of Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 (HLGN.WS) in Q4 2023, closing a stake of 242,523 shares — an estimated $8.95K sold.

D.E. Shaw & Co first reported a position in HLGN.WS in Q4 2021 and held it in 8 quarters. The position peaked at $420K in Q4 2021. 3 funds tracked by Wall St. Rank hold HLGN.WS as of Q4 2023.

  • D.E. Shaw & Co reported no remaining Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position as of Q4 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 242,523 Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 shares in Q4 2023, an estimated $8.95K.
  • D.E. Shaw & Co first reported a position in Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 in Q4 2021 and held it in 8 quarters.
  • D.E. Shaw & Co's Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 position peaked at $420K in Q4 2021.
  • 3 funds tracked by Wall St. Rank held Heliogen, Inc. Redeemable Warrants, Each whole warrant is exercisable for 1/35th of a share of Common Stock at an exercise price of $402.50 as of Q4 2023.

Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.